With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. * Design, plan, and execute laboratory experiments for drug product formulation development in collaboration with Drug Product Labs and Process Development colleagues, applying current Quality by Design (QbD) principles
mehr